Literature DB >> 28935638

Phagocytosis of microparticles by alveolar macrophages during acute lung injury requires MerTK.

Michael P Mohning1,2, Stacey M Thomas1, Lea Barthel1, Kara J Mould2, Alexandria L McCubbrey1,2, S Courtney Frasch3, Donna L Bratton3, Peter M Henson2,3, William J Janssen1,2.   

Abstract

Microparticles are a newly recognized class of mediators in the pathophysiology of lung inflammation and injury, but little is known about the factors that regulate their accumulation and clearance. The primary objective of our study was to determine whether alveolar macrophages engulf microparticles and to elucidate the mechanisms by which this occurs. Alveolar microparticles were quantified in bronchoalveolar fluid of mice with lung injury induced by LPS and hydrochloric acid. Microparticle numbers were greatest at the peak of inflammation and declined as inflammation resolved. Isolated, fluorescently labeled particles were placed in culture with macrophages to evaluate ingestion in the presence of endocytosis inhibitors. Ingestion was blocked with cytochalasin D and wortmannin, consistent with a phagocytic process. In separate experiments, mice were treated intratracheally with labeled microparticles, and their uptake was assessed though microscopy and flow cytometry. Resident alveolar macrophages, not recruited macrophages, were the primary cell-ingesting microparticles in the alveolus during lung injury. In vitro, microparticles promoted inflammatory signaling in LPS primed epithelial cells, signifying the importance of microparticle clearance in resolving lung injury. Microparticles were found to have phosphatidylserine exposed on their surfaces. Accordingly, we measured expression of phosphatidylserine receptors on macrophages and found high expression of MerTK and Axl in the resident macrophage population. Endocytosis of microparticles was markedly reduced in MerTK-deficient macrophages in vitro and in vivo. In conclusion, microparticles are released during acute lung injury and peak in number at the height of inflammation. Resident alveolar macrophages efficiently clear these microparticles through MerTK-mediated phagocytosis.

Entities:  

Keywords:  Mer tyrosine kinase; alveolar macrophage; lung injury; microparticle; phagocytosis

Mesh:

Substances:

Year:  2017        PMID: 28935638      PMCID: PMC6335009          DOI: 10.1152/ajplung.00058.2017

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  45 in total

1.  Observation of antigen-dependent CD8+ T-cell/ dendritic cell interactions in vivo.

Authors:  B C Schaefer; M L Schaefer; J W Kappler; P Marrack; R M Kedl
Journal:  Cell Immunol       Date:  2001-12-15       Impact factor: 4.868

2.  Essential role for MFG-E8 as ligand for alphavbeta5 integrin in diurnal retinal phagocytosis.

Authors:  Emeline F Nandrot; Monika Anand; Dena Almeida; Kamran Atabai; Dean Sheppard; Silvia C Finnemann
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-09       Impact factor: 11.205

Review 3.  Membrane vesicles as conveyors of immune responses.

Authors:  Clotilde Théry; Matias Ostrowski; Elodie Segura
Journal:  Nat Rev Immunol       Date:  2009-06-05       Impact factor: 53.106

Review 4.  Defining macropinocytosis.

Authors:  Markus C Kerr; Rohan D Teasdale
Journal:  Traffic       Date:  2009-01-24       Impact factor: 6.215

Review 5.  Immunobiology of the TAM receptors.

Authors:  Greg Lemke; Carla V Rothlin
Journal:  Nat Rev Immunol       Date:  2008-05       Impact factor: 53.106

6.  Endothelium-derived microparticles induce endothelial dysfunction and acute lung injury.

Authors:  John C Densmore; Paul R Signorino; Jingsong Ou; Ossama A Hatoum; J Jordi Rowe; Yang Shi; Sushma Kaul; Deron W Jones; Robert E Sabina; Kirkwood A Pritchard; Karen S Guice; Keith T Oldham
Journal:  Shock       Date:  2006-11       Impact factor: 3.454

7.  Effects of mechanical ventilation on platelet microparticles in bronchoalveolar lavage fluid.

Authors:  Diana K Mutschler; Anders O Larsson; Samar Basu; Anders Nordgren; Mats B Eriksson
Journal:  Thromb Res       Date:  2002-11-25       Impact factor: 3.944

8.  Procoagulant alveolar microparticles in the lungs of patients with acute respiratory distress syndrome.

Authors:  Julie A Bastarache; Richard D Fremont; Jonathan A Kropski; Frederick R Bossert; Lorraine B Ware
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-08-21       Impact factor: 5.464

9.  Surfactant proteins A and D suppress alveolar macrophage phagocytosis via interaction with SIRP alpha.

Authors:  William J Janssen; Kathleen A McPhillips; Matthew G Dickinson; Derek J Linderman; Konosuke Morimoto; Yi Qun Xiao; Kelly M Oldham; R William Vandivier; Peter M Henson; Shyra J Gardai
Journal:  Am J Respir Crit Care Med       Date:  2008-04-17       Impact factor: 21.405

10.  Phosphatidylserine (PS) induces PS receptor-mediated macropinocytosis and promotes clearance of apoptotic cells.

Authors:  P R Hoffmann; A M deCathelineau; C A Ogden; Y Leverrier; D L Bratton; D L Daleke; A J Ridley; V A Fadok; P M Henson
Journal:  J Cell Biol       Date:  2001-11-12       Impact factor: 10.539

View more
  25 in total

1.  Inhibiting Bruton's tyrosine kinase rescues mice from lethal influenza-induced acute lung injury.

Authors:  Jon M Florence; Agnieszka Krupa; Laela M Booshehri; Sandra A Davis; Michael A Matthay; Anna K Kurdowska
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-03-08       Impact factor: 5.464

Review 2.  Nanotechnology based solutions for anti-leishmanial impediments: a detailed insight.

Authors:  Humzah Jamshaid; Fakhar Ud Din; Gul Majid Khan
Journal:  J Nanobiotechnology       Date:  2021-04-15       Impact factor: 10.435

Review 3.  Microparticles and cardiovascular diseases.

Authors:  Christos Voukalis; Eduard Shantsila; Gregory Y H Lip
Journal:  Ann Med       Date:  2019-06-17       Impact factor: 4.709

Review 4.  Extracellular Vesicles: A New Frontier for Research in Acute Respiratory Distress Syndrome.

Authors:  Rahul Y Mahida; Shotaro Matsumoto; Michael A Matthay
Journal:  Am J Respir Cell Mol Biol       Date:  2020-07       Impact factor: 6.914

5.  Cholesterol 25-hydroxylase promotes efferocytosis and resolution of lung inflammation.

Authors:  Jennifer H Madenspacher; Eric D Morrell; Kymberly M Gowdy; Jeffrey G McDonald; Bonne M Thompson; Ginger Muse; Jennifer Martinez; Seddon Thomas; Carmen Mikacenic; Jerry A Nick; Edward Abraham; Stavros Garantziotis; Renee D Stapleton; Julie M Meacham; Mary Jane Thomassen; William J Janssen; Donald N Cook; Mark M Wurfel; Michael B Fessler
Journal:  JCI Insight       Date:  2020-06-04

6.  Bioinspired particle engineering for non-invasive inhaled drug delivery to the lungs.

Authors:  Snehal K Shukla; Apoorva Sarode; Dipti D Kanabar; Aaron Muth; Nitesh K Kunda; Samir Mitragotri; Vivek Gupta
Journal:  Mater Sci Eng C Mater Biol Appl       Date:  2021-07-15

7.  Polymeric Microparticles: Synthesis, Characterization and In Vitro Evaluation for Pulmonary Delivery of Rifampicin.

Authors:  Faiqa Falak Naz; Kifayat Ullah Shah; Zahid Rasul Niazi; Mansoor Zaman; Vuanghao Lim; Mulham Alfatama
Journal:  Polymers (Basel)       Date:  2022-06-19       Impact factor: 4.967

Review 8.  Emerging drug delivery strategies for idiopathic pulmonary fibrosis treatment.

Authors:  Moez Ghumman; Dinesh Dhamecha; Andrea Gonsalves; Lauren Fortier; Parand Sorkhdini; Yang Zhou; Jyothi U Menon
Journal:  Eur J Pharm Biopharm       Date:  2021-04-18       Impact factor: 5.589

9.  Extracellular vesicles in pulmonary hypertension: lessons from mesenchymal stromal cell-derived exosomes.

Authors:  Jenny L Hewes; Natalie N Bauer
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2019-03-13       Impact factor: 6.011

Review 10.  The Role of Macrophages During Mammalian Tissue Remodeling and Regeneration Under Infectious and Non-Infectious Conditions.

Authors:  Candice Bohaud; Matt D Johansen; Christian Jorgensen; Laurent Kremer; Natacha Ipseiz; Farida Djouad
Journal:  Front Immunol       Date:  2021-07-14       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.